The landscape of N6-methyladenosine in localized primary prostate cancer

被引:0
|
作者
Xu, Xin [1 ]
Zhu, Helen [1 ,2 ,3 ]
Hugh-White, Rupert [4 ,5 ,6 ,7 ]
Livingstone, Julie [4 ,5 ,6 ,7 ]
Eng, Stefan [4 ,5 ,6 ,7 ]
Zeltser, Nicole [4 ,5 ,6 ,7 ]
Wang, Yujuan [1 ]
Pajdzik, Kinga [8 ,9 ]
Chen, Sujun [1 ,2 ,22 ,23 ]
Houlahan, Kathleen E. [2 ,3 ,4 ,5 ,6 ,7 ]
Luo, Wenqin [1 ,10 ]
Liu, Shun [8 ,9 ]
Xu, Xi [1 ]
Sheng, Minzhi [2 ,11 ]
Guo, Wang Yuan [1 ]
Arbet, Jaron [4 ,5 ,6 ,7 ]
Song, Yuxi [4 ,5 ,6 ,7 ]
Wang, Miranda [1 ]
Zeng, Yong [1 ]
Wang, Shiyan [1 ,24 ]
Zhu, Guanghui [1 ,2 ,22 ,23 ]
Gao, Tingxiao [1 ,2 ]
Chen, Wei [1 ,25 ]
Ci, Xinpei [1 ]
Xu, Wenjie [12 ,13 ]
Xu, Kexin [14 ]
Orain, Michele [15 ]
Picard, Valerie [15 ]
Hovington, Helene [15 ]
Bergeron, Alain [15 ]
Lacombe, Louis [15 ]
Tetu, Bernard [15 ]
Fradet, Yves [15 ]
Lupien, Mathieu [1 ,2 ]
Wei, Gong-Hong [12 ,13 ,16 ]
Koritzinsky, Marianne [1 ,2 ]
Bristow, Robert G. [17 ,18 ]
Fleshner, Neil E. [1 ]
Wu, Xue [19 ]
Shao, Yang [19 ,20 ]
He, Chuan [8 ,9 ]
Berlin, Alejandro [1 ]
van der Kwast, Theodorus [1 ]
Leong, Hon [2 ,11 ]
Boutros, Paul C. [2 ,3 ,4 ,5 ,6 ,7 ,21 ]
He, Housheng Hansen [1 ,2 ]
机构
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[3] Vector Inst, Toronto, ON, Canada
[4] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
[7] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA
[8] Univ Chicago, Dept Chem, Chicago, IL 60637 USA
[9] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA
[10] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou, Peoples R China
[11] Sunnybrook Res Inst, Toronto, ON, Canada
[12] Fudan Univ, Sch Basic Med Sci, MOE Key Lab Metab & Mol Med, Shanghai Med Coll, Shanghai, Peoples R China
[13] Fudan Univ, Shanghai Canc Ctr, Sch Basic Med Sci, Dept Biochem,Shanghai Med Coll, Shanghai, Peoples R China
[14] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX USA
[15] Univ Laval, Res Ctr, CHU Quebec, Quebec City, PQ, Canada
[16] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Common Mech Res Major Dis, Suzhou Inst Syst Med, Suzhou, Peoples R China
[17] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[18] Christie NHS Trust & & CRUK Manchester Inst, Manchester, England
[19] Geneseeq Technol lnc, Geneseeq Res Inst, Toronto, ON, Canada
[20] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Peoples R China
[21] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[22] Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[23] Sichuan Univ, State Key Lab Biotherapy, Chengdu, Peoples R China
[24] Sun Yat Sen Univ, Affiliated Hosp 1, Inst Precis Med, Guangzhou, Peoples R China
[25] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Resp & Crit Care Med, Huaian 223000, Jiangsu, Peoples R China
关键词
TRANSCRIPTION FACTORS; COPY NUMBER; R PACKAGE; GENE; TRANSLATION; DISCOVERY; VERSICAN; MUTATIONS; EVOLUTION; HALLMARKS;
D O I
10.1038/s41588-025-02128-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
N6-methyladenosine (m6A), the most abundant internal RNA modification in humans, regulates most aspects of RNA processing. Prostate cancer is characterized by widespread transcriptomic dysregulation; therefore, we characterized the m6A landscape of 162 localized prostate tumors with matched DNA, RNA and protein profiling. m6A abundance varied dramatically across tumors, with global patterns emerging via complex germline-somatic cooperative regulation. Individual germline polymorphisms regulated m6A abundance, cooperating with somatic mutation of cancer driver genes and m6A regulators. The resulting complex patterns were associated with prognostic clinical features and established the biomarker potential of global and locus-specific m6A patterns. Tumor hypoxia dysregulates m6A profiles, bridging prior genomic and proteomic observations. Specific m6A sites, such as those in VCAN, drive disease aggression, associating with poor outcomes, tumor growth and metastasis. m6A dysregulation is thus associated with key events in the natural history of prostate cancer: germline risk, microenvironmental dysregulation, somatic mutation and metastasis.
引用
收藏
页码:934 / 948
页数:39
相关论文
共 50 条
  • [1] Functions and mechanisms of N6-methyladenosine in prostate cancer
    Wan, Hongyuan
    Feng, Yanyan
    Wu, Junjie
    Zhu, Lijie
    Mi, Yuanyuan
    MOLECULAR MEDICINE REPORTS, 2022, 26 (03)
  • [2] Role of N6-methyladenosine modification in cancer
    Deng, Xiaolan
    Su, Rui
    Feng, Xuesong
    Wei, Minjie
    Chen, Jianjun
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2018, 48 : 1 - 7
  • [3] Landscape of N6-Methyladenosine Modification Patterns in Human Ameloblastoma
    Niu, Xing
    Xu, Jingping
    Liu, Jinwen
    Chen, Lijie
    Qiao, Xue
    Zhong, Ming
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] Regulation of Gene Expression by N6-methyladenosine in Cancer
    Liu, Jun
    Harada, Bryan T.
    He, Chuan
    TRENDS IN CELL BIOLOGY, 2019, 29 (06) : 487 - 499
  • [5] The RNA N6-methyladenosine modification landscape of human fetal tissues
    Xiao, Shan
    Cao, Shuo
    Huang, Qitao
    Xia, Linjian
    Deng, Mingqiang
    Yang, Mengtian
    Jia, Guiru
    Liu, Xiaona
    Shi, Junfang
    Wang, Weishi
    Li, Yuan
    Liu, Sun
    Zhu, Haoran
    Tan, Kaifen
    Luo, Qizhi
    Zhong, Mei
    He, Chunjiang
    Xia, Laixin
    NATURE CELL BIOLOGY, 2019, 21 (05) : 651 - +
  • [6] Roles and implications of mRNA N6-methyladenosine in cancer
    Zeng, Lingxing
    Huang, Xudong
    Zhang, Jialiang
    Lin, Dongxin
    Zheng, Jian
    CANCER COMMUNICATIONS, 2023, 43 (07) : 729 - 748
  • [7] N6-methyladenosine links RNA metabolism to cancer progression
    Dai, Dongjun
    Wang, Hanying
    Zhu, Liyuan
    Jin, Hongchuan
    Wang, Xian
    CELL DEATH & DISEASE, 2018, 9
  • [8] N6-Methyladenosine: A Novel RNA Imprint in Human Cancer
    Yu, Sihui
    Li, Xi
    Liu, Shiyun
    Yang, Rui
    Liu, Xiangnan
    Wu, Sufang
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [9] Insights into N6-methyladenosine and programmed cell death in cancer
    Liu, Li
    Li, Hui
    Hu, Dingyu
    Wang, Yanyan
    Shao, Wenjun
    Zhong, Jing
    Yang, Shudong
    Liu, Jing
    Zhang, Ji
    MOLECULAR CANCER, 2022, 21 (01)
  • [10] N6-methyladenosine regulates glycolysis of cancer cells through PDK4
    Li, Zihan
    Peng, Yanxi
    Li, Jiexin
    Chen, Zhuojia
    Chen, Feng
    Tu, Jian
    Lin, Shuibin
    Wang, Hongsheng
    NATURE COMMUNICATIONS, 2020, 11 (01)